+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Fractional Flow Reserve Market (2019-2025)

  • ID: 4871822
  • Report
  • November 2019
  • Region: Asia Pacific
  • 98 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bracco S.p.A. and
  • General Electric (GE) Co
  • Koninklijke Philips N.V.
  • Medtronic PLC
The Asia Pacific Fractional Flow Reserve Market is expected to grow at a CAGR of 11.5% during 2019 -2025. The China market dominated the Asia Pacific Fractional Flow Reserve Market by Country 2018, thereby, growing at a CAGR of 9.1 % during the forecast period.

The Asia Pacific fractional flow reserve market will continue to see a significant rise in the years ahead due to increased cases of diabetes and cardiovascular disease and also due to a surge in disposable income. Furthermore, it is also projected that the introduction of favorable laws for medical devices is expected to encourage the growth of the regional market. For example, an agreement was signed in Korea on 15 March 2012. This agreement made medical devices duty-free, thus increasing their adoption rate.

Measurements of fractional flow reserve (FFR) can determine the hemodynamic meaning of coronary artery stenoses. In the absence of non-invasive ischemia data, current guidelines suggest their use in lesions. The prognostic effect of FFR has been tested in randomized trials and it has been shown that revascularization can be safely deferred when FFR is beyond 0.80. The revascularization of stenoses with FFR values is somewhat lower than medical treatment.

Aorto-ostial lesions left main stenoses, and also patients with left ventricular hypertrophy & severely-impaired ejection fraction are excluded from large, randomized trials. The measurements derived through FFR are relatively convenient to perform. However, the uncertainty about procedural logistics and data acquisition and interpretation in specific situations can explain why they are not used extensively in clinical practice.

Due to the introduction of technologically advanced monitoring systems, FFR monitoring systems are expected to witness lucrative growth. Fysicon, for example, launched QMAPP Hemodynamic Monitoring System posting the U.S. FDA in 2017. This system has critical parameters for patient tracking as well as 32 intracardiac bipolar channels for electrophysiology procedures.

FFR guide wires accounted for a dominant market share in 2018 due to their widespread use in diagnostic cardiovascular procedures. This segment is expected to have a stable CAGR over the forecast period due to the increased use of coronary artery disease diagnosis worldwide. For example, according to the Centers for Disease Control and Prevention (CDC), in 2015, nearly 370,000 people died of coronary artery disease in the United States. In addition, elderly people are more prone to heart disorders. The growing population of geriatrics, therefore, supports the development of the segment.

Based on Product, the market is segmented into FFR guidewires and FFR Monitoring Systems. Based on Application, the market is segmented into Multi-Vessel Coronary Artery Disease and Single-Vessel Coronary Artery Disease. The report also covers geographical segmentation of Asia Pacific Fractional Flow Reserve market. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.

Key companies profiled in the report include Medtronic PLC, Terumo Corporation, B. Braun Melsungen AG, General Electric (GE) Co, Siemens AG (Siemens Healthineers), Koninklijke Philips N.V., Boston Scientific Corporation, Abbott Laboratories, Bracco S.p.A. and Opsens, Inc.

Scope of the Study

Market Segmentation:

By Product
  • FFR guidewires and
  • FFR Monitoring Systems

By Application
  • Multi-Vessel Coronary Artery Disease and
  • Single-Vessel Coronary Artery Disease

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Medtronic PLC
  • Terumo Corporation
  • B. Braun Melsungen AG
  • General Electric (GE) Co
  • Siemens AG (Siemens Healthineers)
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bracco S.p.A. and
  • Opsens, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Bracco S.p.A. and
  • General Electric (GE) Co
  • Koninklijke Philips N.V.
  • Medtronic PLC

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Fractional Flow Reserve Market, by Product
1.4.2 Asia Pacific Fractional Flow Reserve Market, by Application
1.4.3 Asia Pacific Fractional Flow Reserve Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
Chapter 3. Market Analysis
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Collaborations, Partnerships, and Agreements : 2019-Oct - 2016-Aug) Leading Players
Chapter 4. Asia Pacific Fractional Flow Reserve Market by Product
4.1 Asia Pacific FFR guidewires Market by Country
4.2 Asia Pacific FFR Monitoring Systems Market by Country
Chapter 5. Asia Pacific Fractional Flow Reserve Market by Application
5.1 Asia Pacific Multi-Vessel Coronary Artery Disease Market by Country
5.2 Asia Pacific Single-Vessel Coronary Artery Disease Market by Country
Chapter 6. Asia Pacific Fractional Flow Reserve Market by Country
6.1 China Fractional Flow Reserve Market
6.1.1 China Fractional Flow Reserve Market by Product
6.1.2 China Fractional Flow Reserve Market by Application
6.2 Japan Fractional Flow Reserve Market
6.2.1 Japan Fractional Flow Reserve Market by Product
6.2.2 Japan Fractional Flow Reserve Market by Application
6.3 India Fractional Flow Reserve Market
6.3.1 India Fractional Flow Reserve Market by Product
6.3.2 India Fractional Flow Reserve Market by Application
6.4 South Korea Fractional Flow Reserve Market
6.4.1 South Korea Fractional Flow Reserve Market by Product
6.4.2 South Korea Fractional Flow Reserve Market by Application
6.5 Singapore Fractional Flow Reserve Market
6.5.1 Singapore Fractional Flow Reserve Market by Product
6.5.2 Singapore Fractional Flow Reserve Market by Application
6.6 Malaysia Fractional Flow Reserve Market
6.6.1 Malaysia Fractional Flow Reserve Market by Product
6.6.2 Malaysia Fractional Flow Reserve Market by Application
6.7 Rest of Asia Pacific Fractional Flow Reserve Market
6.7.1 Rest of Asia Pacific Fractional Flow Reserve Market by Product
6.7.2 Rest of Asia Pacific Fractional Flow Reserve Market by Application
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments
7.1.5.1 Acquisition and Mergers
7.1.5.2 Product Launches
7.1.6 SWOT Analysis
7.2 Terumo Corporation
7.2.1 Company Overview
7.2.1 Financial Analysis
7.2.2 Segmental Analysis
7.2.3 Recent strategies and developments
7.2.3.1 Collaborations, Partnerships, and Agreements
7.2.3.2 Acquisition and Mergers
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments
7.3.5.1 Collaborations, Partnerships, and Agreements
7.4 General Electric (GE) Co.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments
7.4.5.1 Collaborations, Partnerships, and Agreements
7.4.6 SWOT Analysis
7.5 Siemens AG (Siemens Healthineers)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments
7.5.5.1 Collaborations, Partnerships, and Agreements
7.5.6 SWOT Analysis
7.6 Koninklijke Philips N.V.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments
7.6.5.1 Collaborations, Partnerships, and Agreements
7.6.5.2 Acquisition and Mergers
7.6.5.3 Product Launches
7.6.6 SWOT Analysis
7.7 Boston Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments
7.7.5.1 Expansions
7.7.6 SWOT Analysis
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments
7.8.5.1 Acquisition and Mergers
7.8.5.2 Product Launches
7.8.6 SWOT Analysis
7.9 Bracco S.p.A.
7.9.1 Company Overview
7.9.2 Regional Analysis
7.1 Opsens, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments
7.10.5.1 Collaborations, Partnerships, and Agreements
Note: Product cover images may vary from those shown
  • Medtronic PLC
  • Terumo Corporation
  • B. Braun Melsungen AG
  • General Electric (GE) Co
  • Siemens AG (Siemens Healthineers)
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Bracco S.p.A. and
  • Opsens, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...